Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG. (Q45384951)

From Wikidata

Jump to navigation Jump to search

scientific article published on 8 September 2011

Language	Label	Description	Also known as
English	Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG.	scientific article published on 8 September 2011

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG. (English)

1 reference

Europe PubMed Central

14 December 2017

diffuse midline glioma

0 references

0 references

1 reference

based on heuristic

inferred from title

6

object named as

Eric Bouffet

1 reference

Europe PubMed Central

14 December 2017

1

object named as

Ute Bartels

1 reference

Europe PubMed Central

14 December 2017

Cynthia Hawkins

2

object named as

Cynthia Hawkins

1 reference

Europe PubMed Central

14 December 2017

author name string

Gilbert Vézina

3

1 reference

Europe PubMed Central

14 December 2017

Larry Kun

4

1 reference

Europe PubMed Central

14 December 2017

Mark Souweidane

5

1 reference

Europe PubMed Central

14 December 2017

publication date

8 September 2011

1 reference

Europe PubMed Central

14 December 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

14 December 2017

105

1 reference

Europe PubMed Central

14 December 2017

1

1 reference

Europe PubMed Central

14 December 2017

119-125

1 reference

Europe PubMed Central

14 December 2017

https://scigraph.springernature.com/pub.10.1007/s11060-011-0704-4

0 references

Diffuse brainstem glioma in children: critical review of clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Trends in reported incidence of primary malignant brain tumors in children in the United States.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Hyperfractionated radiation therapy for brain-stem glioma: a phase I-II trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherap

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Results of a pilot study of hyperfractionated radiation therapy for children with brain stem gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Permanent I-125 brain stem implants in children.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Long-term outcome of high-precision radiotherapy in patients with brain stem gliomas: results from a difficult-to-treat patient population using fractionated stereotactic radiotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Long-term outcome of 89 low-grade brain-stem gliomas after interstitial radiation therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Fractionated stereotactic conformal radiation therapy of brain stem gliomas: outcome and prognostic factors.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Radiation associated brainstem injury

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Chemotherapy for brain stem gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: final results of BSG 98 prospective trial

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

What have we learnt from previous phase II trials to help in the management of childhood brain tumours?

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Treatment of paediatric pontine glioma with oral trophosphamide and etoposide

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Nimotuzumab for pediatric diffuse intrinsic pontine gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Post mortem examinations in diffuse intrinsic pontine glioma: challenges and chances

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumo

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I study of everolimus in pediatric patients with refractory solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0704-4

21 January 2018

Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-011-0704-4

1 reference

Europe PubMed Central

14 December 2017

Dimensions Publication ID

0 references

release_jqrkt2rpqneyxodtbteirqwtmu

1 reference

https://api.fatcat.wiki/v0/release/jqrkt2rpqneyxodtbteirqwtmu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45384951&oldid=1835415567"